Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers

Applied Thermal Engineering · Elsevier

Аннотация

Publication date: September 2026 Source: Pulmonary Pharmacology & Therapeutics, Volume 94 Author(s): Jens M. Hohlfeld, Meike Müller, Philipp Badorrek, Laurent B. Nicolas, Oliver Vit, William G. Darby, Judith Field, Michael Larbig

Читать у издателя →

Похожие статьи